Loading organizations...
§ Private Profile · 1601 Market St Suite 1500, Philadelphia, PA 19103, USA
AI employees that automate medical operations for clinics.
Novoflow has raised $31.5M across 2 funding rounds.
Key people at Novoflow.
Novoflow was founded in 2025 by Mathieu Rihet (Founder) and Georges Casassovici (Founder).
Novoflow has raised $31.5M in total across 2 funding rounds.
Novoflow is building AI employees that automate medical operations for clinics. Novoflow built the universal bridge into EHR systems:so every workflow, from scheduling to billing, can finally run on AI. The first product is an AI employee that talks to patients and uses computer agents to book, reschedule, and recover cancelled appointments. Built for healthcare providers and hospitals.
Novoflow was founded in 2025 by Mathieu Rihet (Founder) and Georges Casassovici (Founder).
Novoflow has raised $31.5M in total across 2 funding rounds.
Novoflow's investors include Justin Hamilton, Multifaceted Capital, N1, Standard Partners, Pareto Holdings, Samsung NEXT Ventures, Y Combinator.
Novoflow has raised $31.5M across 2 funding rounds. Most recently, it raised $31.0M Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 11, 2026 | $31M Seed | Justin Hamilton | Multifaceted Capital, N1, Standard Partners | Announced |
| May 1, 2025 | $500K Seed | — | Pareto Holdings, Samsung Next Ventures, Y Combinator | Announced |
Novoflow is a healthcare technology startup that builds AI employees to automate medical clinic operations such as scheduling, billing, reminders, and prescription refills by integrating directly with electronic health record (EHR) systems like Epic, Athena, and Medent. Their flagship product is a multilingual AI voice agent that handles inbound and outbound calls, schedules appointments inside any EHR, and reduces patient no-shows, enabling clinics to reclaim up to $50,000 per month in lost revenue without hiring additional staff. Novoflow serves multi-location specialty groups in radiology, dermatology, rheumatology, and primary care, positioning itself as the operating system for medical clinics. The company has raised $3.1 million in funding, including from Y Combinator and angel investors, and is scaling a small but focused team in San Francisco[1][2][3][4].
Novoflow was founded in 2025 by two teenage co-founders, Georges and Mathieu, who previously worked as French and Spanish medical interpreters. They observed firsthand how communication barriers and outdated clinic operations led to lost revenue and delayed care. This experience inspired them to create a voice AI solution that integrates universally with legacy EHR systems to automate clinic workflows. Their approach quickly gained traction, leading to acceptance into Y Combinator’s Spring 2025 batch and raising $3.1 million in seed funding. Early adopters have reported significant improvements in provider utilization and call-to-appointment conversion rates[1][2][3].
Novoflow rides the wave of AI-driven automation and digital transformation in healthcare, addressing the persistent inefficiencies caused by fragmented and outdated EHR systems. The timing is critical as clinics face increasing pressure to reduce operational costs, improve patient engagement, and optimize provider time amid growing healthcare demand. By automating front-office tasks with AI, Novoflow helps clinics overcome legacy software limitations and staff shortages, contributing to a broader shift toward AI-enabled healthcare operations. Their solution also aligns with trends in multilingual patient communication and personalized care, enhancing accessibility and patient satisfaction. Novoflow’s success could accelerate adoption of AI employees in healthcare, influencing the startup ecosystem by demonstrating the viability of AI to solve complex operational challenges in regulated industries[1][2][4].
Novoflow is poised for rapid growth as it expands its clinic partnerships and enhances its AI capabilities. Future trends shaping its journey include increased adoption of AI in healthcare administration, growing demand for multilingual patient engagement, and continued pressure on clinics to optimize revenue cycle management. As Novoflow scales, it may evolve into a comprehensive operating system for clinics, integrating more deeply with clinical workflows and expanding automation beyond administrative tasks. Its influence could extend to setting new standards for AI-human collaboration in healthcare operations, reducing burnout, and improving care delivery efficiency. For investors and healthcare providers alike, Novoflow represents a compelling intersection of AI innovation and practical impact on medical practice management[1][2][4][5].
Key people at Novoflow.
